Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 409

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid

Open access
Park, Jae H., Qiao, Baozhen, Panageas, Katherine S., Schymura, Maria J., Jurcic, Joseph G., Rosenblat, Todd L., Altman, Jessica K., Douer, Dan, Rowe, Jacob M., Tallman, Martin S.·2011·Blood

Abstract

The incidence of early death in a large population of unselected patients with acute promyelocytic leukemia (APL) remains unknown because of the paucity of outcome data available for patients treated outside of clinical trials. We undertook an epidemiologic study to estimate the true rate of early death with data from the Surveillance, Epidemiology, and End Results (SEER) program. A total of 1400 patients with a diagnosis of APL between 1992 and 2007 were identified. The overall early death rate was 17.3%, and only a modest change in early death rate was observed over time. The early death rate was significantly higher in patients aged ≥ 55 years (24.2%; P < .0001). The 3-year survival improved from 54.6% to 70.1% over the study period but was significantly lower in patients aged ≥ 55 years (46.4%; P < .0001). This study shows that the early death rate remains high despite the wide availability of all-trans retinoic acid and appears significantly higher than commonly reported in multicenter clinical trials. These data highlight a need to educate health care providers across a wide range of medical fields, who may be the first to evaluate patients with APL, to have a major effect on early death and the cure rate of APL.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2011-04-346437

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 409

Metadata

Authors
Park, J. H., Qiao, B., Panageas, K. S., Schymura, M. J., Jurcic, J. G., Rosenblat, T. L., Altman, J. K., Douer, D., Rowe, J. M., & Tallman, M. S.
Venue
Blood
Published
2011-08-04
Volume
118
Issue
5
Pages
1248-1254
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W1987176851
Cited by
409
References
30
FWCI
11.29
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid. https://app.cochat.ai/papers/10.1182/blood-2011-04-346437
The paper
Park, J. H., Qiao, B., Panageas, K. S., Schymura, M. J., Jurcic, J. G., Rosenblat, T. L., Altman, J. K., Douer, D., Rowe, J. M., & Tallman, M. S. (2011). Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid. Blood. https://doi.org/10.1182/blood-2011-04-346437

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.